Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
30 January 2014Website:
http://www.eigerbio.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 28 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
EIGR Latest News
Healthcare companies fell sharply Monday as ebullience about a new class of weight control drugs subsided.
Eiger BioPharmaceuticals (NASDAQ: EIGR ) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial. According to a press release from the company, it has discontinued its Phase 3 LIMT-2 study.
Wall Street Analysts have high expectations for Eiger. Eiger has a modest pipeline. Expect near term data to impact the stock in a big way.
What type of business is Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California.
What sector is Eiger BioPharmaceuticals in?
Eiger BioPharmaceuticals is in the Healthcare sector
What industry is Eiger BioPharmaceuticals in?
Eiger BioPharmaceuticals is in the Biotechnology industry
What country is Eiger BioPharmaceuticals from?
Eiger BioPharmaceuticals is headquartered in United States
When did Eiger BioPharmaceuticals go public?
Eiger BioPharmaceuticals initial public offering (IPO) was on 30 January 2014
What is Eiger BioPharmaceuticals website?
https://www.eigerbio.com
Is Eiger BioPharmaceuticals in the S&P 500?
No, Eiger BioPharmaceuticals is not included in the S&P 500 index
Is Eiger BioPharmaceuticals in the NASDAQ 100?
No, Eiger BioPharmaceuticals is not included in the NASDAQ 100 index
Is Eiger BioPharmaceuticals in the Dow Jones?
No, Eiger BioPharmaceuticals is not included in the Dow Jones index
When does Eiger BioPharmaceuticals report earnings?
Next earnings report date is not announced yet